Work

261 Patient characteristics, treatment patterns and real-world effectiveness of niraparib in France: an ESME retrospective study in recurrent ovarian cancer patients treated with niraparib maintenance

Year: 2024

Type: article

Study design: Observational Study

Source: International Journal of Gynecological Cancer

DOI: 10.1136/ijgc-2024-esgo.603

Authors: Laurence Gladieff, Pauline Macouillard, Philippe Toussaint, Nadia El-Mouaddin, Virginie Jacquemin, Anne Fages, Gaëlle Nachbaur, Sophie Gourgou, Christophe Pomel, Pierre-Emmanuel Colombo, Lise Bosquet, Manuel Rodrigues

Institutions: Institut universitaire du cancer de Toulouse Oncopole, Institut Claudius Regaud, UniCancer Group, Centre Léon Bérard, GlaxoSmithKline (France), Institut Regional du Cancer de Montpellier, Centre Jean Perrin, Institut Curie

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4392631891

FWCI:

Cites:

Cited by:

Related to: 10